Experimental design | Group A (n = 45) | Group B (n = 45) |
|---|
1 × 105 CFU | 1 × 104 CFU |
|---|
| | No-IE | Faint IE | Severe IE | No-IE | Faint IE | Severe IE |
|---|
ΔPRA (0–5 mmHg) | 12/15 (80%) | 3/15 (20%) | 0/15 (0%) | 14/15 (93.3%) | 1/15 (6.7%) | 0/15 (0%) |
ΔPRA (5–10 mmHg) | 0/15 (0%) | 14/15 (93.3%) | 1/15 (6.7%) | 12/15 (80%) | 3/15 (20%) | 0/15 (0%) |
ΔPRA (10–15 mmHg) | 0/15 (0%) | 4/15 (26.7%) | 11/15 (73.3%) | 10/15 (66.7%) | 5/15 (33.3%) | 0/15 (0%) |
-
No-IE: Did not develop IE by echocardiography or by histologic findings; Faint IE: Infectious endocarditis could confirmed by histologic findings but not visualized by echocardiography; Severe IE: Infectious endocarditis confirmed by both echocardiography and histologic findings. LV: Left ventricle; RV: Right ventricle; V
TR
: Peak velocity of tricuspid valve regurgitation; ΔP
RA
: Right atrial pressure before and just after valvular impairment was used to calculate alterations of right atrial pressure, indicated as ΔPRA.
